Stay updated on Nefecon in Primary IgA Nephropathy: Clinical Trial

Sign up to get notified when there's something new on the Nefecon in Primary IgA Nephropathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nefecon in Primary IgA Nephropathy: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    An NIH banner announcing a transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to related updates and FAQs was removed.
    Difference
    1%
    Check dated 2026-11-08T13:40:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:01:50.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” in its content. The clinical study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:56:43.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:11:52.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:13:59.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous content for the study record. This change adds the 403 header/footer while removing extensive study details and related metadata from the page.
    Difference
    17%
    Check dated 2026-09-20T11:19:51.000Z thumbnail image

Stay in the know with updates to Nefecon in Primary IgA Nephropathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nefecon in Primary IgA Nephropathy: Clinical Trial page.